What is a lipoprotein(a) test?

A lipoprotein(a) or Lp(a) blood test measures the concentration of Lp(a) particles in your blood. Lp(a) is a genetically influenced lipoprotein linked to heart attack, stroke, and aortic valve disease. In Australia it is a standard pathology assay available through GP-ordered or private panels.

How much does an Lp(a) test cost in Australia?

A standalone private Lp(a) test typically costs $40 to $90 out of pocket when added to a GP request. It is often bundled in advanced lipid or heart health panels ($80 to $300+). Comprehensive membership platforms that include Lp(a) among 70+ markers start around AU$799 per year. Medicare rarely funds Lp(a) for routine asymptomatic screening.

Is Lp(a) covered by Medicare in Australia?

Medicare funds standard lipid panels when clinically indicated. Lp(a) for routine preventative screening in asymptomatic adults is usually not Medicare-funded and is paid privately. Your GP may order it with specific clinical justification in some cases.

What is a normal Lp(a) level in Australia?

Australian labs commonly report Lp(a) in nmol/L with reference ranges that vary by laboratory. Many use roughly 75 to 125 nmol/L as a discussion threshold for elevated risk, with higher concern above 125 nmol/L. Some labs still report mg/dL. Always use the reference interval on your Australian lab report.

How often should Lp(a) be tested?

Lp(a) is largely genetically determined and stable through life. International guidance supports measuring it at least once in adulthood. Repeat testing is not routine unless assay methods change, results are ambiguous, or a specialist recommends confirmation. Hemexa includes Lp(a) on the annual baseline panel as a lifetime reference.

Do I need to fast for an Lp(a) test?

Lp(a) alone does not require fasting. If your blood draw also includes triglycerides, fasting glucose, or insulin on the same request, follow 8 to 12 hour fasting instructions on your lab slip unless your clinician advises otherwise.

How do I get an Lp(a) test in Australia?

You need an authorised pathology request from a registered GP or clinician. Options include asking your GP for a private Lp(a) add-on, ordering through a pay-per-panel service with GP review, or joining a membership like Hemexa that includes Lp(a) on the annual panel. Blood is collected at Laverty, 4Cyte, or other pathology centres nationwide.

Who should get an Lp(a) test?

Lp(a) is worth considering if you have family history of early heart disease or stroke, premature aortic stenosis, cardiovascular disease with normal LDL, or familial hypercholesterolaemia. Many preventative programs include a one-time Lp(a) baseline for healthy adults. Your GP or cardiologist can advise based on your history.

Can you lower Lp(a) with diet or statins?

Lp(a) is mostly genetically determined. Lifestyle changes and statins do not reliably lower it enough to remove inherited risk. Current care focuses on aggressively managing modifiable factors: LDL or ApoB, blood pressure, smoking, diabetes, and inflammation. Lp(a)-specific therapies are emerging in clinical trials.

What is the difference between Lp(a) and ApoB?

Lp(a) measures a specific inherited lipoprotein particle. ApoB counts total atherogenic particles (LDL, VLDL, and Lp(a) combined). Both contribute to cardiovascular risk. A complete heart panel often includes Lp(a) once in life plus ApoB and standard lipids for ongoing monitoring.

What is lipoprotein little a?

Lipoprotein little a is a common spoken name for lipoprotein(a), abbreviated Lp(a). It is the same blood test and marker. Search terms like "Lp(a) test", "lipoprotein a test", and "lipoprotein(a) Australia" refer to the same assay.

Does Hemexa include Lp(a)?

Yes. Lipoprotein(a) is included on the Hemexa annual signature panel as part of 60+ signature markers across 16 health-system categories. Because Lp(a) is genetically stable, it is stored as a lifetime baseline on the heart dashboard while modifiable markers are tracked on structured retests. Membership is AU$799/year with GP-reviewed requests and Laverty collection.

Guide

Lipoprotein(a) testing in Australia

Lipoprotein(a), written Lp(a) and sometimes called "lipoprotein little a", is a cholesterol-carrying particle largely determined by your LPA gene. Blood levels are stable from early adulthood and rarely change with diet or exercise. An Lp(a) test measures that inherited cardiovascular risk. In Australia it is usually a private pathology add-on because Medicare rarely funds Lp(a) for routine screening in asymptomatic adults, yet guidelines increasingly recommend measuring it at least once in life.

Hemexa includes Lipoprotein(a) on the annual signature panel alongside ApoB, standard lipids, and hs-CRP. This guide explains what Lp(a) measures, why a one-time test matters, how to order it in Australia, and how to interpret results with your clinician.

Your annual baseline includes 60+ signature markers (exact count depends on sex; typically 59–63 measured). Fast-moving markers are tested again on your included six-month retest.

See all 60+ markers

Lp(a) on annual panelGP-reviewed requestsLifetime baseline stored

Why it matters

Why measure Lp(a)?

Standard lipid panels miss a major piece of cardiovascular risk. Lp(a) is an independent, genetically driven risk factor for heart attack, stroke, and aortic valve disease. Knowing your level helps you and your clinician interpret family history and plan prevention, even when LDL cholesterol looks fine.

Genetic risk standard lipids miss

Roughly one in five people have elevated Lp(a). Many have normal LDL and no obvious risk factors until an event occurs. A single Lp(a) test can explain "unexpected" early heart disease in families.

Independent of LDL cholesterol

Lp(a) raises risk on its own. You can have low LDL and high Lp(a), or high LDL and low Lp(a). That is why preventative cardiologists pair Lp(a) with ApoB, LDL, and hs-CRP for a complete picture.

Stable for life: test once

Lp(a) levels are set early and change little with age, diet, or most medications. International guidance supports measuring Lp(a) at least once in adulthood. Retesting is only needed if assay methods change or clinical guidelines recommend confirmation.

Marker comparison

Lp(a) vs LDL, ApoB, and other lipids

Australian GPs often order a standard lipid panel at a check-up. Lp(a) is a separate assay. Understanding how markers differ prevents false reassurance when LDL looks normal but inherited risk is high.

Marker	What it measures	Medicare	Best for
LDL cholesterol (LDL-C)	Cholesterol mass inside LDL particles	Often funded when clinically indicated	Standard screening and statin monitoring
Apolipoprotein B (ApoB)	Total atherogenic lipoprotein particle count	Usually private out of pocket	Particle burden when LDL is borderline or discordant
Lipoprotein(a) (Lp(a))	Genetically determined Lp(a) particle concentration	Usually private; one-time baseline often recommended	Family history of early heart disease, unclear lipid risk, aortic stenosis workup
hs-CRP	Low-grade systemic inflammation	Sometimes funded with cardiovascular risk assessment	Inflammatory component of residual risk

Australian context

How Lp(a) testing works in Australia

Lp(a) is a standard NATA-accredited assay at major Australian pathology labs. The practical questions are Medicare billing, units on the report, and whether your panel includes it by default.

Medicare rarely covers routine Lp(a)

Medicare funds lipid panels when clinically necessary. Lp(a) for asymptomatic preventative screening is typically an out-of-pocket add-on, often $40 to $90 standalone or bundled in advanced heart health panels.

GP-reviewed request required

As with all pathology in Australia, Lp(a) needs an authorised request from a registered medical practitioner. Legitimate direct-to-consumer services include GP clinical review before the lab order is issued.

nmol/L vs mg/dL on reports

Australian labs increasingly report Lp(a) in nmol/L (particle number). Some still use mg/dL. Do not compare raw numbers across unit systems without conversion. Use the reference interval printed on your Australian lab report.

Who should test

Who should consider an Lp(a) test?

Lp(a) is not needed for everyone, but a one-time test is increasingly recommended when family history or unexplained cardiovascular risk suggests inherited lipid burden. Discuss with your GP or cardiologist.

Family history of early heart disease or stroke

Parents or siblings with heart attack, stroke, or sudden cardiac death before age 60, especially with "normal" cholesterol, is the classic indication for Lp(a) testing.

Personal history despite normal LDL

If you have had cardiovascular disease or aortic stenosis and standard lipids do not explain the risk, Lp(a) may be the missing inherited factor.

Borderline or unexplained lipid results

When LDL, ApoB, and lifestyle do not match perceived risk, a one-time Lp(a) test clarifies whether genetics are driving particle-related risk.

Premature aortic stenosis

Elevated Lp(a) is linked to calcific aortic valve disease at younger ages. Cardiologists often check Lp(a) when stenosis appears earlier than expected.

Preventative baseline while healthy

Because Lp(a) only needs measuring once, many Australians include it in a first comprehensive preventative panel alongside ApoB, lipids, and hs-CRP.

Known familial hypercholesterolaemia

Lp(a) stacks with LDL-driven risk in familial hypercholesterolaemia. Measuring both helps set targets and discuss intensified prevention.

How to order

Four ways Australians get an Lp(a) test

From a Medicare lipid panel with a private add-on to a comprehensive membership that includes Lp(a) on the annual baseline. Costs and convenience vary.

Approach	Best for	Typical cost	Lp(a) included?
GP lipid panel (Medicare)	Standard cardiovascular screening	Bulk-billed or low gap	Usually no; LDL, HDL, triglycerides only
GP-ordered Lp(a) add-on (private)	One-time inherited risk check when your doctor agrees	~$40 to $90 out of pocket	Yes, as a single marker or small add-on panel
Pay-per-panel services (e.g. MediTests, i-screen)	One-off cardiovascular or comprehensive panels	~$80 to $300+ depending on panel	Often included in advanced lipid or heart panels
Membership platforms (e.g. Hemexa)	Annual comprehensive panel with Lp(a) baseline stored in dashboard	~$799/year (full membership)	Yes; Lp(a) on annual panel among 60+ signature markers

Results

Understanding your Lp(a) result

Australian labs report Lp(a) with local reference ranges, usually in nmol/L. Interpretation should always involve your clinician. These are general reference points, not personal medical advice.

Common Australian reference thresholds

Many labs flag elevated Lp(a) above roughly 75 to 125 nmol/L, with higher risk often discussed above 125 nmol/L (about 50 mg/dL in older unit systems). Exact cut-offs vary by lab and guideline. Use the interval on your report.

High Lp(a) does not mean imminent disease

Elevated Lp(a) raises lifetime cardiovascular and aortic stenosis risk but does not predict when an event will occur. Clinicians weigh Lp(a) alongside blood pressure, smoking, diabetes, LDL or ApoB, and family history.

Lifestyle still matters

Diet and exercise do not reliably lower Lp(a), but they reduce overall cardiovascular risk. Treating modifiable factors aggressively is standard when Lp(a) is high.

Emerging therapies

Lp(a)-lowering drugs (for example pelacarsen and olpasiran) are in clinical trials. PCSK9 inhibitors may lower Lp(a) modestly. Discuss options with a cardiologist or lipid clinic if your level is high and family history is strong.

What moves Lp(a)

What affects Lp(a) levels?

Lp(a) is one of the least lifestyle-responsive lipid markers. Focus on what you can change for overall heart health, and use Lp(a) to personalise how aggressively you manage modifiable risk.

Genetics dominate

The LPA gene determines apolipoprotein(a) isoform size and plasma concentration. Levels are relatively stable from young adulthood through later life.

Diet and exercise have limited effect

Mediterranean eating patterns and weight loss may lower Lp(a) slightly in some people, but not reliably enough to treat high Lp(a) with lifestyle alone.

Statins do not lower Lp(a) meaningfully

Statins reduce LDL but typically do not correct high Lp(a). They remain important for overall LDL and ApoB control when those are also elevated.

Control what you can

Blood pressure, smoking cessation, glucose control, ApoB or LDL targets, and inflammation (hs-CRP) are the main levers when Lp(a) is high. Aggressive management of modifiable risk is the current standard of care.

Ordering checklist

What to check before you book an Lp(a) test

Confirm Lp(a) is on the request form

Standard Medicare lipid panels omit Lp(a). Ask your GP or verify your private panel lists Lipoprotein(a) (LOINC 10839-9 or equivalent).

Plan for a one-time baseline

Because Lp(a) is genetically stable, one well-documented result is usually enough for life. Store the PDF or dashboard record where future clinicians can find it.

Pair with ApoB and standard lipids

Lp(a) explains inherited risk; ApoB and LDL show modifiable particle burden. A complete heart panel often includes all three plus hs-CRP.

Read the units on your report

Australian labs may report nmol/L or mg/dL. Compare your result only to the reference interval on that report, not to overseas cut-offs in a different unit.

Discuss family screening

If your Lp(a) is high, first-degree relatives may benefit from testing. Share your result with siblings and parents where appropriate.

No fasting required for Lp(a) alone

Lp(a) can be drawn non-fasting. If combined with triglycerides or glucose on the same tube, follow fasting instructions on your lab slip.

How Hemexa fits

Lp(a) as part of a tracked cardiovascular panel

Hemexa includes Lipoprotein(a) on the annual signature panel with ApoB, standard lipids, and hs-CRP. Your Lp(a) baseline stays on the heart dashboard while modifiable markers trend on structured retests.

Lp(a) on the annual signature panel

Hemexa includes Lipoprotein(a) on the annual baseline panel as part of 60+ signature markers across heart and circulation markers. You get Lp(a) with ApoB, LDL, HDL, triglycerides, and hs-CRP in one coordinated draw.

Lifetime marker, stored in your dashboard

Lp(a) is genetically stable, so it is treated as a lifetime baseline marker rather than a six-month retest target. Your result stays on the heart dashboard for future clinical discussions.

Heart-system context

Lp(a) appears alongside modifiable cardiovascular markers so you can see inherited risk in context with ApoB, lipids, and inflammation trends on structured retests.

GP-reviewed requests and Laverty collection

Hemexa coordinates authorised pathology requests and nationwide collection through Laverty. No separate Lp(a) add-on shopping or ad-hoc lab orders.

Hemexa dashboard showing heart health scores and Lipoprotein(a) baseline

Decision helper

GP add-on or membership with Lp(a) included?

Choose GP or pay-per-panel if

You only need a one-off Lp(a) test and will store the PDF yourself
Your GP will order a private Lp(a) add-on and you do not need a broader membership
You already have comprehensive panels elsewhere and only want this single marker

Choose Hemexa membership if

You want Lp(a) as part of a comprehensive annual panel with modifiable markers retested
You want Lp(a) stored alongside ApoB, lipids, glucose, insulin, and inflammation in one dashboard
You want one membership that coordinates GP-reviewed requests, Laverty collection, and longitudinal tracking

Pair Lp(a) with particle-level testing in our ApoB test guide or read the preventative blood test guide.

FAQ

Common questions about Lp(a) testing in Australia

What is a lipoprotein(a) test?: A lipoprotein(a) or Lp(a) blood test measures the concentration of Lp(a) particles in your blood. Lp(a) is a genetically influenced lipoprotein linked to heart attack, stroke, and aortic valve disease. In Australia it is a standard pathology assay available through GP-ordered or private panels.
How much does an Lp(a) test cost in Australia?: A standalone private Lp(a) test typically costs $40 to $90 out of pocket when added to a GP request. It is often bundled in advanced lipid or heart health panels ($80 to $300+). Comprehensive membership platforms that include Lp(a) among 70+ markers start around AU$799 per year. Medicare rarely funds Lp(a) for routine asymptomatic screening.
Is Lp(a) covered by Medicare in Australia?: Medicare funds standard lipid panels when clinically indicated. Lp(a) for routine preventative screening in asymptomatic adults is usually not Medicare-funded and is paid privately. Your GP may order it with specific clinical justification in some cases.
What is a normal Lp(a) level in Australia?: Australian labs commonly report Lp(a) in nmol/L with reference ranges that vary by laboratory. Many use roughly 75 to 125 nmol/L as a discussion threshold for elevated risk, with higher concern above 125 nmol/L. Some labs still report mg/dL. Always use the reference interval on your Australian lab report.
How often should Lp(a) be tested?: Lp(a) is largely genetically determined and stable through life. International guidance supports measuring it at least once in adulthood. Repeat testing is not routine unless assay methods change, results are ambiguous, or a specialist recommends confirmation. Hemexa includes Lp(a) on the annual baseline panel as a lifetime reference.
Do I need to fast for an Lp(a) test?: Lp(a) alone does not require fasting. If your blood draw also includes triglycerides, fasting glucose, or insulin on the same request, follow 8 to 12 hour fasting instructions on your lab slip unless your clinician advises otherwise.
How do I get an Lp(a) test in Australia?: You need an authorised pathology request from a registered GP or clinician. Options include asking your GP for a private Lp(a) add-on, ordering through a pay-per-panel service with GP review, or joining a membership like Hemexa that includes Lp(a) on the annual panel. Blood is collected at Laverty, 4Cyte, or other pathology centres nationwide.
Who should get an Lp(a) test?: Lp(a) is worth considering if you have family history of early heart disease or stroke, premature aortic stenosis, cardiovascular disease with normal LDL, or familial hypercholesterolaemia. Many preventative programs include a one-time Lp(a) baseline for healthy adults. Your GP or cardiologist can advise based on your history.
Can you lower Lp(a) with diet or statins?: Lp(a) is mostly genetically determined. Lifestyle changes and statins do not reliably lower it enough to remove inherited risk. Current care focuses on aggressively managing modifiable factors: LDL or ApoB, blood pressure, smoking, diabetes, and inflammation. Lp(a)-specific therapies are emerging in clinical trials.
What is the difference between Lp(a) and ApoB?: Lp(a) measures a specific inherited lipoprotein particle. ApoB counts total atherogenic particles (LDL, VLDL, and Lp(a) combined). Both contribute to cardiovascular risk. A complete heart panel often includes Lp(a) once in life plus ApoB and standard lipids for ongoing monitoring.
What is lipoprotein little a?: Lipoprotein little a is a common spoken name for lipoprotein(a), abbreviated Lp(a). It is the same blood test and marker. Search terms like "Lp(a) test", "lipoprotein a test", and "lipoprotein(a) Australia" refer to the same assay.
Does Hemexa include Lp(a)?: Yes. Lipoprotein(a) is included on the Hemexa annual signature panel as part of 60+ signature markers across 16 health-system categories. Because Lp(a) is genetically stable, it is stored as a lifetime baseline on the heart dashboard while modifiable markers are tracked on structured retests. Membership is AU$799/year with GP-reviewed requests and Laverty collection.

Claim a founding spot and we will send next steps when onboarding opens. Or browse all 60+ signature markers before you decide.

All guides